Impact of a peer virtual community on pregnant women's well-being: A repeated-measure and quasi-experimental study

J Adv Nurs. 2019 May;75(5):1099-1107. doi: 10.1111/jan.13938. Epub 2019 Jan 24.

Abstract

Aim: To investigate the effects of a virtual community on pregnant women's well-being.

Background: The virtual social network has been growing rapidly but its effects remain unclear.

Design: A repeated-measure and quasi-experimental study.

Methods: We designed a closed Facebook community for peer-to-peer interaction with no mediator. A total of 121 pregnant women were assigned to either experimental or control group. Data were collected from May 2012-January 2015 using five instruments related to pregnant women's well-being.

Results: Significant differences on pregnant women's well-being were not found between groups. However, higher adherence to the virtual community was significantly related to first-time pregnant women and women whose pregnancy was assisted by a technology treatment.

Conclusions: Nurses and midwifes are recommended to pay more attentions on first-time pregnant women and women whose pregnancy was assisted by a technology treatment regarding their pregnancy-related concerns.

Trial registration number: ClinicalTrials.gov NCT03692923.

目的: 研究虚拟社区对孕妇健康的影响。 背景: 虚拟社交网络发展迅速,但其影响仍不明朗。 设计: 重复测量和准实验研究。 方法: 我们设计了一个封闭的Facebook社区,供同行之间进行互动,不需要任何中间人。共有121名孕妇被分为实验组和对照组。数据收集于2012年5月至2015年1月,使用了五种与孕妇健康相关的仪器。 结果: 两组孕妇的健康状况没有显著差异。然而,第一次怀孕的女性和通过技术治疗辅助怀孕的女性对虚拟社区的依附性更高。 结论: 建议护士和助产士更多地关注初次怀孕的孕妇和通过技术治疗辅助怀孕的妇女,以解决她们与怀孕有关的问题。 试验注册号码: ClinicalTrials.gov NCT03692923.

Keywords: depression; maternal-fetal relations; nursing; pregnancy; pregnancy adaptation; social support; virtual community.

MeSH terms

  • Adult
  • Female
  • Health Promotion / methods*
  • Humans
  • Obstetric Nursing / methods*
  • Peer Group
  • Pregnancy
  • Pregnancy Complications / prevention & control*
  • Pregnant Women / education*
  • Pregnant Women / psychology*
  • Social Media*
  • Taiwan
  • Virtual Reality*

Associated data

  • ClinicalTrials.gov/NCT03692923